These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 21915630

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo.
    Mookerjee A, Basu JM, Majumder S, Chatterjee S, Panda GS, Dutta P, Pal S, Mukherjee P, Efferth T, Roy S, Choudhuri SK.
    BMC Cancer; 2006 Nov 15; 6():267. PubMed ID: 17107616
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reversal of resistance against doxorubicin by a newly developed compound, oxalyl bis(N-phenyl)hydroxamic acid in vitro.
    Choudhuri SK, Chatterjee A.
    Anticancer Drugs; 1998 Oct 15; 9(9):825-32. PubMed ID: 9840730
    [Abstract] [Full Text] [Related]

  • 6. A novel manganese complex, Mn-(II) N-(2-hydroxy acetophenone) glycinate overcomes multidrug-resistance in cancer.
    Ghosh RD, Banerjee K, Das S, Ganguly A, Chakraborty P, Sarkar A, Chatterjee M, Choudhuri SK.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):737-47. PubMed ID: 23665413
    [Abstract] [Full Text] [Related]

  • 7. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro.
    Banerjee K, Biswas MK, Choudhuri SK.
    J Biol Inorg Chem; 2017 Dec 16; 22(8):1223-1249. PubMed ID: 29063196
    [Abstract] [Full Text] [Related]

  • 8. Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative.
    Ganguly A, Banerjee K, Chakraborty P, Das S, Sarkar A, Hazra A, Banerjee M, Maity A, Chatterjee M, Mondal NB, Choudhuri SK.
    Biomed Pharmacother; 2011 Sep 16; 65(6):387-94. PubMed ID: 21715129
    [Abstract] [Full Text] [Related]

  • 9. An in vitro and in vivo study of a novel zinc complex, zinc N-(2-hydroxyacetophenone)glycinate to overcome multidrug resistance in cancer.
    Ghosh RD, Das S, Ganguly A, Banerjee K, Chakraborty P, Sarkar A, Chatterjee M, Nanda A, Pradhan K, Choudhuri SK.
    Dalton Trans; 2011 Nov 07; 40(41):10873-84. PubMed ID: 21717020
    [Abstract] [Full Text] [Related]

  • 10. Menadione reduced doxorubicin resistance in Ehrlich ascites carcinoma cells in vitro.
    Xu CJ, Zhang Y, Wang J, Zhang TM.
    Zhongguo Yao Li Xue Bao; 1998 May 07; 19(3):273-6. PubMed ID: 10375743
    [Abstract] [Full Text] [Related]

  • 11. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
    Mookerjee A, Mookerjee Basu J, Dutta P, Majumder S, Bhattacharyya S, Biswas J, Pal S, Mukherjee P, Raha S, Baral RN, Das T, Efferth T, Sa G, Roy S, Choudhuri SK.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4339-49. PubMed ID: 16857809
    [Abstract] [Full Text] [Related]

  • 12. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
    Shinoda C, Maruyama M, Fujishita T, Dohkan J, Oda H, Shinoda K, Yamada T, Miyabayashi K, Hayashi R, Kawagishi Y, Fujita T, Matsui S, Sugiyama E, Muraguchi A, Kobayashi M.
    Int J Cancer; 2005 Oct 20; 117(1):21-31. PubMed ID: 15880572
    [Abstract] [Full Text] [Related]

  • 13. Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff's base to overcome MDR in cancer.
    Basu S, Ganguly A, Chakraborty P, Sen R, Banerjee K, Chatterjee M, Efferth T, Choudhuri SK.
    Biochimie; 2012 Jan 20; 94(1):166-83. PubMed ID: 22037022
    [Abstract] [Full Text] [Related]

  • 14. N-acetylcysteine enhances multidrug resistance-associated protein 1 mediated doxorubicin resistance.
    Akan I, Akan S, Akca H, Savas B, Ozben T.
    Eur J Clin Invest; 2004 Oct 20; 34(10):683-9. PubMed ID: 15473893
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Elevated glutathione is not sufficient to protect against doxorubicin-induced nuclear damage in heart in multidrug resistance-associated protein 1 (Mrp1/Abcc1) null mice.
    Deng J, Coy D, Zhang W, Sunkara M, Morris AJ, Wang C, Chaiswing L, St Clair D, Vore M, Jungsuwadee P.
    J Pharmacol Exp Ther; 2015 Nov 20; 355(2):272-9. PubMed ID: 26354996
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The triterpenoid fraction from Trichosanthes dioica root exhibits antiproliferative activity against Ehrlich ascites carcinoma in albino mice: involvement of possible antioxidant role.
    Bhattacharya S, Haldar PK.
    J Exp Ther Oncol; 2012 Nov 20; 9(4):281-90. PubMed ID: 22545421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.